Experts arent certain what causes ankylosing spondylitis
For patients with significant weight to lose, staying on treatment longer consistently produces better outcomes
doi: 10.1016/j.ejphar.2020.173581 35 TuXKChenPPChenJYDingYHChenQShiSS
Research using visual analogue scales and food consumption assessments indicates decreased hunger ratings, lower portion sizes, and enhanced regulation of overeating tendencies (Aldawsari et al
Typical schedules include: Starting Phase : Low initial dose (e.g., 2.5 mg/week) for 12 weeks to monitor response
New FDA policy on compounding GLP-1 drugs New FDA policy on compounding GLP-1 drugs On April 24, 2025, FDA announced that licensed pharmacies and physicians can no longer compound semaglutide (a GLP-1 drug used in Ozempic & Wegovy) and outsourcing facilities must stop production by May 22, 2025